- CConnexion
RééDOC
75 Boulevard Lobau 54042 NANCY cedex Christelle Grandidier Documentaliste 03 83 52 67 64 0
|
Pregabalin for the treatment of fibromyalgia syndrome
CROFFORD LJ; ROWBOTHAM MC; MEASE PJ; RUSSELL IJ; DWORKIN RH; CORBIN AE; YOUNG JP; LAMOREAUX L; MARTIN SA; SHARMA U
ARTHRITIS RHEUM , 2005, vol. 52, n° 4, p. 1264-1273 Doc n°: 119747 Localisation : Documentation IRR Descripteurs : DA52 - MALADIES RHUMATISMALES Fibromyalgia syndrome (FMS) is characterized by widespread musculoskeletal pain and lowered pain threshold. Other prominent symptoms include disordered sleep and fatigue. FMS affects an estimated 2% of the population, predominantly women. This trial was designed to evaluate the efficacy and safety of pregabalin, a novel alpha(2)-delta ligand, for treatment of symptoms associated with FMS. Methods. This multicenter, double-blind, Langue : ANGLAIS Tiré à part : OUI |
0
|